Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

The Odisha government is set to host the Odisha Pharma Summit 2025 on December 16. This event aims to unite stakeholders from the pharmaceutical and medical devices industries to explore new opportunities. Chief Minister Mohan Charan Majhi will inaugurate the programme. An official mentioned that the state will introduce the Odisha Pharmaceutical and Medical Devices Policy 2025 during this event.

The new policy is designed to attract investments, enhance business ease, and generate large-scale employment in the life sciences sector. Additionally, the government plans to announce the development of a Pharmaceutical Park and a Medical Devices Park. These initiatives aim to bolster the state’s healthcare manufacturing infrastructure and promote industry growth.

Focus on Industry Growth
Industries Minister Sampad Chandra Swain stated, “Odisha welcomes all pharma, medical devices & related sector industries, investors, and thought leaders to join us at this summit. We are committed to building a strong, future-ready ecosystem that supports growth, innovation, and global competitiveness.” The summit will also feature the signing of MoUs between the government and leading companies.

This collaboration marks a significant step towards enhancing the state’s pharmaceutical and medical devices ecosystem. The government encourages healthcare and industry enthusiasts to participate in this initiative, which aims to shape the future of the sector in Odisha.

The event’s agenda includes discussions on investment opportunities and strategies for improving business operations in the life sciences field. By bringing together industry leaders and investors, Odisha aims to position itself as a hub for pharmaceutical and medical device manufacturing.

Related Posts

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

New Delhi:  The demand for nebulisers, inhalers and respiratory medicines for children has surged sharply in Delhi during winter months, with chemists reporting spikes of up to 60 per cent…

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Rajkot: The Narcotics Control Bureau (NCB) on Monday said it has secured a “major conviction” in the case of illegal diversion of medical drugs involving a Haryana-based company via Gujarat’s Pipavav…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

DoP may exempt 11 more drugs from public procurement rules

DoP may exempt 11 more drugs from public procurement rules